Posterior reversible encephalopathy syndrome with bevacizumab

Hong Kong Medical Journal

Volumn 17, Issue 1, 2011, Pages 80-81

  Lau, Patrick C P ^a   Paunipagar, Bhawan ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON CARCINOMA; COLON RESECTION; DROWSINESS; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PARTIAL HEPATECTOMY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; RECTUM RESECTION; TEMPORAL LOBE; VISUAL DISORDER; WHITE MATTER;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; MIDDLE AGED; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME;

EID: 79951500312     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001;219:756-65.
2. Glusker P, Recht L, Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006;354:980-1.
3. Ozcan C, Wong SJ, Hari P. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006;354:981-2.